Duke University Hospital will take part in the first national tests of a drug that could be effective in treating COVID-19. Duke patients with significant symptoms of COVID-19 will be given the option to participate in the trial, which will begin immediately and be limited to adults. Richard Stradling writes in Raleigh News Observer that the treatment, known as remdesivir, is an antiviral agent previously tested in humans with Ebola virus disease.